Today: 13 June 2026
Browse Category

Stock Market 14 November 2025

Caterpillar (CAT) Stock Today: Wells Fargo Starts at Overweight as Volume Momentum Builds — November 14, 2025

Caterpillar (CAT) Stock Today: Wells Fargo Starts at Overweight as Volume Momentum Builds — November 14, 2025

Caterpillar shares closed Thursday at $553.55, down 3.4% amid a global market selloff. Wells Fargo initiated coverage Friday with an Overweight rating and a $675 price target, joining several firms raising targets after strong Q3 results. Year-to-date, CAT is up over 50%. Recent analysis highlights a $1.55 billion rise in Q3 sales volumes, the company’s strongest volume recovery since 2023.
14 November 2025
·
Expion360 (XPON) Soars After Q3 2025 Earnings Beat: Revenue Up 72% as New CEO Takes the Helm

Expion360 (XPON) Soars After Q3 2025 Earnings Beat: Revenue Up 72% as New CEO Takes the Helm

Expion360 (NASDAQ: XPON) stock surged over 28% after hours to $1.63 following a surprise Q3 2025 profit and a 72% revenue jump to $2.4 million. The company reported GAAP EPS of $0.10, reversing a large loss last year. Cash rose to $4.3 million, and new CEO Joseph Hammer and CFO Shawna Bowin took over. Despite the rally, XPON shares remain down 63% year over year.
14 November 2025
··
Ron Baron Says He’ll Never Sell His Tesla or SpaceX Stock: What His Bold Bet on Elon Musk Means for Investors Today

Ron Baron Says He’ll Never Sell His Tesla or SpaceX Stock: What His Bold Bet on Elon Musk Means for Investors Today

Ron Baron told CNBC he does not plan to sell his Tesla or SpaceX shares during his lifetime, reaffirming his long-term commitment to Elon Musk’s companies. His comments come days after Tesla shareholders approved Musk’s $1 trillion pay package. Baron Capital has invested over $1.7 billion in Tesla and SpaceX, with Musk-linked holdings now making up about 26% of the firm’s assets.
14 November 2025
···
Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health shares fell about 7–8% to $36.05 Friday after launching its new Labs diagnostic platform with Quest Diagnostics. The company’s market cap stands near $8.2 billion. Labs offers nationwide blood testing and health monitoring through annual subscriptions. The stock remains up roughly 43% year-to-date but trades well below its 52-week high.
14 November 2025
··
IREN Limited (IREN) Stock Plunges 12% as AI ‘Neocloud’ Trade Stumbles – Despite $9.7B Microsoft Deal (14 November 2025)

IREN Limited (IREN) Stock Plunges 12% as AI ‘Neocloud’ Trade Stumbles – Despite $9.7B Microsoft Deal (14 November 2025)

IREN shares fell 12.7% to $48.65 Friday afternoon, extending a one-week drop to nearly 36% despite a $9.7 billion Microsoft AI cloud contract and record results. The stock remains up almost 300% over the past year. Broader AI-infrastructure stocks, including CoreWeave and Nebius, also declined this week after cautious analyst notes and guidance cuts.
14 November 2025
·
Virgin Galactic (SPCE) Narrows Q3 Loss, Reaffirms 2026 Space Tourism Launch as Stock Trades Near Lows

Virgin Galactic (SPCE) Narrows Q3 Loss, Reaffirms 2026 Space Tourism Launch as Stock Trades Near Lows

Virgin Galactic reported a Q3 2025 net loss of $64 million, down from $75 million a year earlier, with revenue flat at $0.4 million. Cash and securities totaled $424 million at quarter’s end. The company reaffirmed plans to launch private astronaut flights in late 2026. SPCE shares closed at $3.31, down 8.6% after earnings and over 40% year-to-date.
14 November 2025
···
Invivyd (IVVD) Rockets Over 50% Pre‑Market on November 14, 2025 as Traders Rush Into COVID Antibody Play

Invivyd (IVVD) Rockets Over 50% Pre‑Market on November 14, 2025 as Traders Rush Into COVID Antibody Play

Invivyd shares surged as much as 58% in pre-market trading Friday, reaching $2.80 before 8:00 a.m. ET, according to RTTNews. The stock was among the top gainers on Wall Street, with no new company press release issued since its November 6 earnings report. Market data showed IVVD trading between $2.47 and $2.80, up 39% to 58% from Thursday’s $1.77 close.
14 November 2025
·
MDA Space Stock Plunges Over 50% on SpaceX Shock, But Q3 2025 Earnings and Wireless Power Deal Rekindle Bull Hopes

MDA Space Stock Plunges Over 50% on SpaceX Shock, But Q3 2025 Earnings and Wireless Power Deal Rekindle Bull Hopes

MDA Space shares have dropped over 55% from their 52-week high after EchoStar canceled a $1.3 billion satellite contract and sold spectrum to SpaceX. The company reported strong Q3 2025 results and reaffirmed guidance on November 14, but market focus remains on lost backlog and customer shifts toward SpaceX.
14 November 2025
·····
Visa–Mastercard Swipe Fee Settlement 2025: How Credit Card Checkout and Rewards Are About to Change

Visa–Mastercard Swipe Fee Settlement 2025: How Credit Card Checkout and Rewards Are About to Change

Visa and Mastercard have proposed a $38 billion settlement in a long-running antitrust case, aiming to cut average credit-card swipe fees for U.S. merchants and loosen card-acceptance rules. The deal, filed in Brooklyn federal court, awaits approval. Separately, payouts from an earlier $5.5 billion settlement are expected to reach merchants in early 2026.
14 November 2025
··
Stock Market Today, November 14, 2025: Global Sell-Off Deepens as Fed Rate-Cut Hopes Fade and Tech Rout Batters Dow, S&P 500, Nasdaq Futures

Stock Market Today, November 14, 2025: Global Sell-Off Deepens as Fed Rate-Cut Hopes Fade and Tech Rout Batters Dow, S&P 500, Nasdaq Futures

Global stock markets fell sharply Friday as doubts over a December Fed rate cut and concerns about high AI and tech valuations triggered a broad sell-off. U.S. rate-cut odds dropped to about 50%, down from over 60% earlier in the week. Bond yields hovered near 4%, while the yen and Swiss franc gained. Oil rose on supply fears; gold traded near record highs.
14 November 2025
·
Robinhood’s Wild 2025 Ride: HOOD Stock Skyrockets 200%, Plunges 9% in a Day – What’s Next?

Robinhood (HOOD) Stock: What to Know Before the U.S. Market Opens Today – November 14, 2025

Robinhood shares fell 8.61% to $121.53 on Thursday and dropped another 5.6% in pre-market trading Friday, following the launch of a new cash-delivery service and fresh regulatory scrutiny. The stock is down around 13–14% over two days, despite being up over 200% year-to-date. Trading volume surged to 36.4 million shares Thursday. Broader tech and crypto markets also slid.
14 November 2025
·
Cisco Stock Surges Near 52-Week High on AI Momentum – What’s Next for CSCO?

Cisco Stock (CSCO) Today: 10 Things to Know Before the US Market Opens – November 14, 2025

Cisco closed Thursday at $77.38, up over 4% after fiscal Q1 2026 results beat expectations on revenue and earnings. The company reported $14.9 billion in revenue and $1.00 non-GAAP EPS, driven by strong AI networking demand and Splunk integration. Cisco booked $1.3 billion in AI orders for the quarter and expects $3 billion in AI infrastructure revenue for fiscal 2026. Shares are trading near a 12-month high.
14 November 2025
·
Disney Stock Could Soar? Analysts Pin 20% Upside on Streaming Shake-Up and Park Growth

Disney Stock (DIS) Today: What to Know Before the US Market Opens on November 14, 2025

Disney shares fell 7.8% to $107.61 Thursday after Q4 revenue missed estimates, despite gains in streaming and parks. Premarket trading Friday showed little further movement, with the stock near $107.17. The company faces a prolonged ESPN/ABC blackout on YouTube TV, costing an estimated $30 million per week. Management doubled its buyback target to $7 billion and set a $1.50 annual dividend for fiscal 2026.
14 November 2025
··
Verizon Stock Takes a Hit: Analyst Downgrade and CEO Shake-Up Rattle Investors

Verizon Stock Today, November 14, 2025: What Investors Need to Know Before the US Market Opens

Verizon shares traded slightly higher pre-market Friday after the company announced plans to cut about 15,000 jobs, or 15% of its workforce, in its largest-ever restructuring under new CEO Dan Schulman. The stock closed Thursday at around $41.10, up nearly 0.8%, and indicated further gains early Friday. Layoffs could begin as soon as next week. Market cap stands near $173 billion.
14 November 2025
·
AT&T Stock Faces Crucial Test: 5G Spectrum Gamble, Fiber Expansion & Earnings Loom

AT&T Stock (T) Before the Bell: Data Breach Payouts, 5G Subway Rollout and Big-Money Flows – What to Know Today (Nov. 14, 2025)

AT&T shares traded near $25.80 in light premarket action Friday, up 0.1% from Thursday’s close, as U.S. equity futures slipped on rate concerns. The company faces heightened scrutiny after agreeing to a $177 million class-action settlement over two 2024 data breaches that exposed customer data. Affected customers can claim up to $7,500 for losses. The claim deadline is mid-December.
14 November 2025
··
Micron’s AI-Fueled Stock Surge: Record Earnings, Rallying Shares & What’s Next for MU

Micron Technology (MU) Stock Today: What to Know Before the US Market Opens – November 14, 2025

Micron Technology shares traded around $232.50 pre-market Friday, down nearly 2% after closing at $236.95, a 3.3% drop Thursday amid a tech sell-off. Morgan Stanley raised its price target to a Street-high $325, citing surging DRAM prices and bullish earnings forecasts. Despite the upgrade, Micron remains under pressure as investors rotate out of high-growth chip stocks.
14 November 2025
·
1 … 1,396 1,397 1,398 1,399 1,400 … 1,549

Stock Market Today

  • Ascletis Pharma Stock Falls 41.6% in a Month, Valuation Mixed Amid Losses
    June 13, 2026, 12:37 AM EDT. Ascletis Pharma (SEHK:1672) shares dropped 4.4% last week and 41.6% over the past month, raising questions about its valuation. The stock trades at a price-to-book (P/B) ratio of 4.7x, above the Hong Kong Biotech sector average of 3.2x but below a peer group average of 12.5x, signaling mixed valuation metrics. The company remains unprofitable with a negative return on equity of 18.61%, making earnings-based measures less relevant. While longer-term returns remain positive, recent revenue and net income weaknesses alongside ongoing losses pose risks. Investors are advised to review underlying data carefully before deciding on Ascletis Pharma's stock prospects amid a cautious market sentiment.

Latest articles

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

NCR Voyix Rallies 10% After Investors Shift on Turnaround Bets

13 June 2026
NCR Voyix soared 10.25% to $7.85, far outpacing the market, as investors focus on the company’s 2026 cash-flow and earnings targets; the next key catalyst is the Q2 2026 earnings update, with stock valuation appearing low if management delivers on margin and cash-flow goals, but risks remain with declining reported revenue and high debt.
Go toTop